Immunovia AB (publ) is a Sweden-based diagnostic company that is developing and commercializing blood tests for the early detection of cancer and autoimmune diseases based on Immunoviaâ€™s test platform called IMMray. Tests are based on antibody biomarker microarray analysis using machine-learning and bioinformatics to single-out a set of relevant biomarkers that indicate a certain disease. Thus, forming a disease biomarker signature. Immunovia Dx Laboratories locations in USA and Sweden provides laboratory testing services in two accredited reference laboratories.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

11-05 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume

Delayed Quote London S.E.

More quotes

EPS Estimates

Evolution of Analysts' Estimates - EPS - Immunovia AB

Revisions to estimates

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Immunovia AB

Company calendar

Market Closed - London S.E. 15:45:34 03/11/2025 GMT			After hours 16:25:00
31.92 ^SEK	-32.03%		0.0620	-99.81%

10-05	23 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange	FW
10-05	Immunovia no longer has any public short sellers	FW

Market Cap	47.83M 4.79M 4.26M 3.98M 3.61M 6.82M 462M 6.87M 18.6M 236M 17.99M 17.61M 758M	P/E 2026 *	-0.71x	P/E 2027 *	-1.78x
Enterprise Value	12.83M 1.29M 1.14M 1.07M 968K 1.83M 124M 1.84M 4.99M 63.22M 4.83M 4.72M 203M	EV / Sales 2026 *	4.01x	EV / Sales 2027 *	1.03x
Free-Float	90.23%	Yield 2026 *	-	Yield 2027 *	-

10-05	23 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange	FW
10-05	Immunovia no longer has any public short sellers	FW
10-05	Immunovia: Pancreasure detected 77.5 percent of early-stage pancreatic cancer cases, according to analysis	FW
10-02	28 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange	FW
09-29	Stockholm exchange loses momentum, OMXS30 index up 0.2 percent	FW
09-29	Stockholm continues higher at midday, Hemnet rises on reorganization	FW
09-29	20 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange	FW
09-29	Boozt rises on positive Stockholm market, OMXS30 index up 0.7%	FW
09-29	Uneven opening expected on Stockholm Stock Exchange	FW
09-29	Immunovia To Carry Out Rights Issue Of About SEK 63 Million	RE
09-29	Immunovia seeks to raise approximately SEK 63m in rights issue	FW
09-28	Immunovia Seeks Medicare Reimbursement for Pancreasure	FW
09-28	Immunovia AB Submits Formal Request for Medicare Coverage of PancreaSure	CI

26/02/25	Carlsquare initiates assignment monitoring of Immunovia	FW
30/12/23	Bonesupport winner of the year and Viaplay loser of the year on Nasdaq Stockholm 2023	FW

Immunovia AB Share Price London S.E.

Stocks

0G8X

SE0006091997

Advanced Medical Equipment & Technology

Valuation: Immunovia AB

Chart: Immunovia AB

Latest news: Immunovia AB

Last Transcript: Immunovia AB

Analysts' recommendations: Immunovia AB

Press Releases: Immunovia AB

Quotes and Performance

Price Extremes

Managers and Directors: Immunovia AB

Medical Diagnostic & Testing Equipment

Financials

Company Profile

Quotes

Quarterly revenue - Rate of surprise

10-05	Immunovia publishes data on PancreaSure in hereditary and familial high-risk individuals	AQ
09-29	Equity research, Immunovia: Announced rights issue and pause of coverage	AQ
09-28	NOTICE OF EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB (PUBL)	AQ
09-28	Immunovia carries out a rights issue of units of approximately SEK 63 million	AQ
09-28	Immunovia submits formal request for Medicare coverage of PancreaSure	AQ

1 day	-32.03%
1 week	+20,654.23%
Current month	+32,638.46%
1 month	+24,682.61%
3 months	+16,370.59%
6 months	+17,042.86%
Current year	+13,658.62%

1 month	0.1	0.32
Current year	0.1	0.32
1 year	0.1	0.35
3 years	0.1	2.78
5 years	0.1	131.5
10 years	0.1	292

Manager	Title	Age	Since
Jeff Borcherding CEO	Chief Executive Officer	53	28/04/2023
Lisa Ford CTO	Chief Tech/Sci/R&D Officer	55	28/04/2024
Norma Alonzo Palma CTO	Chief Tech/Sci/R&D Officer	54	30/01/2024

Director	Title	Age	Since
Hans Olof Gunnar Johansson BRD	Director/Board Member	72	08/12/2016
Peter Andersen CHM	Chairman	70	25/05/2023
Martin Brygger Møller BRD	Director/Board Member	51	31/12/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
IMMUNOVIA AB	-32.03%	+20,654.23%	-	-	4.76M
THERMO FISHER SCIENTIFIC, INC.	-2.98%	-3.24%	+20.85%	+31.84%	250B
DANAHER CORPORATION	-2.53%	-5.16%	+0.29%	-0.58%	156B
INTUITIVE SURGICAL, INC.	-0.42%	-2.42%	-10.52%	+39.53%	144B
BOSTON SCIENTIFIC CORPORATION	-0.50%	-4.35%	-56.65%	-18.36%	61.45B
EDWARDS LIFESCIENCES CORPORATION	-0.86%	-0.40%	+12.21%	+19.78%	50.28B
SIEMENS HEALTHINEERS AG	+1.66%	-1.55%	-20.09%	-20.26%	46.73B
AGILENT TECHNOLOGIES, INC.	-1.00%	-3.36%	+19.55%	+53.45%	48.29B
VEEVA SYSTEMS INC.	+0.02%	+1.26%	-4.31%	+40.76%	45.89B
WATERS CORPORATION	-0.84%	-1.47%	+32.90%	+64.08%	43.24B
Average	-3.72%	-2.32%	-0.64%	+23.36%	93.91B
Weighted average by Cap.	-1.23%	-2.77%	+2.50%	+23.30%

	2026 *	2027 *
Net sales	3.2M 321K 285K 266K 241K 456K 30.92M 459K 1.24M 15.77M 1.2M 1.18M 50.7M	17.3M 1.73M 1.54M 1.44M 1.31M 2.47M 167M 2.48M 6.73M 85.27M 6.51M 6.37M 274M
Net income	-87M -8.72M -7.74M -7.24M -6.57M -12.4M -841M -12.49M -33.84M -429M -32.73M -32.03M -1.38B	-76M -7.62M -6.76M -6.33M -5.74M -10.83M -734M -10.91M -29.56M -375M -28.59M -27.98M -1.2B
Net Debt	-35M -3.51M -3.11M -2.91M -2.64M -4.99M -338M -5.02M -13.61M -173M -13.17M -12.89M -555M	-30M -3.01M -2.67M -2.5M -2.26M -4.28M -290M -4.31M -11.67M -148M -11.29M -11.04M -475M